BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11554731)

  • 1. Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts.
    Ohnaka K; Shimoda S; Nawata H; Shimokawa H; Kaibuchi K; Iwamoto Y; Takayanagi R
    Biochem Biophys Res Commun; 2001 Sep; 287(2):337-42. PubMed ID: 11554731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
    Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
    J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells.
    Maeda T; Matsunuma A; Kurahashi I; Yanagawa T; Yoshida H; Horiuchi N
    J Cell Biochem; 2004 Jun; 92(3):458-71. PubMed ID: 15156558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pitavastatin on apolipoprotein A-I production in HepG2 cell.
    Maejima T; Yamazaki H; Aoki T; Tamaki T; Sato F; Kitahara M; Saito Y
    Biochem Biophys Res Commun; 2004 Nov; 324(2):835-9. PubMed ID: 15474503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures.
    Ruiz-Gaspa S; Nogues X; Enjuanes A; Monllau JC; Blanch J; Carreras R; Mellibovsky L; Grinberg D; Balcells S; Díez-Perez A; Pedro-Botet J
    J Cell Biochem; 2007 Aug; 101(6):1430-8. PubMed ID: 17252541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone upregulates BMP-2 mRNA expression through mevalonate kinase and Rho kinase inhibition in osteoblastic MC3T3-E1 cells.
    Takase H; Yano S; Yamaguchi T; Kanazawa I; Hayashi K; Yamamoto M; Yamauchi M; Sugimoto T
    Horm Metab Res; 2009 Dec; 41(12):861-5. PubMed ID: 19672814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.
    Morikawa-Futamatsu K; Adachi S; Maejima Y; Tamamori-Adachi M; Suzuki J; Kitajima S; Ito H; Isobe M
    Life Sci; 2006 Aug; 79(14):1380-90. PubMed ID: 16712874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts.
    Viereck V; Siggelkow H; Tauber S; Raddatz D; Schutze N; Hüfner M
    J Cell Biochem; 2002; 86(2):348-56. PubMed ID: 12112004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
    Kuo PL; Hsu YL; Chang CH; Chang JK
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells.
    Kim DJ; Moon SH; Kim H; Kwon UH; Park MS; Han KJ; Hahn SB; Lee HM
    Spine (Phila Pa 1976); 2003 Dec; 28(24):2679-84. PubMed ID: 14673369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statin and BMP].
    Ohnaka K; Takayanagi R
    Clin Calcium; 2004 Feb; 14(2):286-8. PubMed ID: 15576985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the mevalonate pathway rescues the dexamethasone-induced suppression of the mineralization in osteoblasts via enhancing bone morphogenetic protein-2 signal.
    Kanazawa I; Yamaguchi T; Yano S; Hayashi K; Yamauchi M; Sugimoto T
    Horm Metab Res; 2009 Aug; 41(8):612-6. PubMed ID: 19384817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
    Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of RhoA/Rho-kinase pathway suppresses the expression of type I collagen induced by TGF-beta2 in human retinal pigment epithelial cells.
    Itoh Y; Kimoto K; Imaizumi M; Nakatsuka K
    Exp Eye Res; 2007 Mar; 84(3):464-72. PubMed ID: 17217948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Rho-associated kinase in differential regulation by statins of interleukin-1beta- and lipopolysaccharide-mediated nuclear factor kappaB activation and inducible nitric-oxide synthase gene expression in vascular smooth muscle cells.
    Wei CY; Huang KC; Chou YH; Hsieh PF; Lin KH; Lin WW
    Mol Pharmacol; 2006 Mar; 69(3):960-7. PubMed ID: 16317111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin suppresses apoptosis in osteoblastic cells: role of transforming growth factor-beta-Smad3 pathway.
    Kaji H; Naito J; Inoue Y; Sowa H; Sugimoto T; Chihara K
    Horm Metab Res; 2008 Nov; 40(11):746-51. PubMed ID: 18622892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
    Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
    Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
    Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
    Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
    Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
    Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitavastatin inactivates NF-kappaB and decreases IL-6 production through Rho kinase pathway in MCF-7 cells.
    Wang J; Kitajima I
    Oncol Rep; 2007 May; 17(5):1149-54. PubMed ID: 17390058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.